Back to results
US 2012/0252840 A1Published application
Method of Treating Cancer
AssigneeExelixis, Inc.
InventorsDana T. Aftab, Frauke Schimmoller
Life of this patent
Estimating the term…
Abstract
This invention is directed to the treatment of cancer, particularly ocular melanoma, with a dual inhibitor of MET and VEGF such as Compound 1.
Claims9
A method for treating melanoma, comprising administering to a patient in need of such treatment a compound of Formula I:
- or a pharmaceutically acceptable salt thereof, wherein:
- R1 is halo;
- R2 is halo;
- R3 is (C1-C6)alkyl;
- R4 is (C1-C6)alkyl;
- and
- Q is CH or N.
4 more elements
A method for treating ocular melanoma comprising administering to a patient in need of such treatment Compound 1 or a pharmaceutically acceptable salt thereof.
Dependencies are inferred from the claim text.